Bioethics Biotechnology Clio Sophia Koller Genetics Health Law Policy Pharmaceuticals Resource Allocation The Luxturna Debate: Why Ethics Needs a Seat at the Drug Pricing Table Read more: The Luxturna Debate: Why Ethics Needs a Seat at the Drug Pricing Table
Health Law Policy Mark Satta Pharmaceuticals Student Fellows Drug Pricing Controls and the Power of Familiar Ideas Read more: Drug Pricing Controls and the Power of Familiar Ideas
Health Law Policy Insurance Medicare/Medicaid Pharmaceuticals Resource Allocation Student Fellows Step therapy explained: An increasingly popular tool for cost control Read more: Step therapy explained: An increasingly popular tool for cost control
Health Care Finance Health Law Policy International Oliver Kim Pharmaceuticals World Trade Month: Trade’s impact on domestic drug prices Read more: World Trade Month: Trade’s impact on domestic drug prices
Dalia Deak Health Law Policy Medicare/Medicaid Pharmaceuticals CMS Issues Notice Regarding Barriers to HCV Treatment Read more: CMS Issues Notice Regarding Barriers to HCV Treatment
Kate Greenwood Pharmaceuticals A New Cholesterol-Lowering Drug at What Price? Read more: A New Cholesterol-Lowering Drug at What Price?
Alex Stein Conflicts of Interest Health Care Finance Health Law Policy Market Design Pharmaceuticals The Tylenol Debate: Can Hospitals be Sued for Excessive Markups on Medications and Devices? Read more: The Tylenol Debate: Can Hospitals be Sued for Excessive Markups on Medications and Devices?